Uterine papillary serous cancer

David G Allen University of Melbourne

Keywords: uterine papillary serous cancer, treatment

Abstract

There is much about the management of endometrial cancer that remains controversial. The literature contains very little good evidence to guide our practice on uterine papillary serous cancer (UPSC). UPSC is an aggressive histological subtype of endometrial cancer, accounting for less than 5% of its incidence, but 40% of its mortality. UPSC has a higher propensity for lymphovascular space invasion (LVSI), and intraperitoneal as well as extra-abdominal spread, than the more common endometrioid cancers.

Author Biography

David G Allen, University of Melbourne

MBChB, MMed(O&G), PhD, FCOG(SA), AFRACMA, FRANZCOG, CGO Gynaecological Oncologist Mercy Hospital for Women Melbourne Australia

David Allen

Issue

Vol 7 No 1 (2015)

Section

Guest Editorial

By submitting manuscripts to SAJGO, authors of original articles are assigning copyright to the South African Society of Gynaecologic Oncology (SASGO). Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in SAJGO for educational and research purposes without obtaining permission.